Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ricardo Romero-Moreno has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Intracellular Lactate Modulation Alters Histone Modifications and CHO Cell Performance in Fed‐Batch Culture

    by Mona Hoseini Soflaee, Ricardo Romero‐Moreno, Bethany Cheng, Nathaniel Chavez, Hui‐Lan Hu, Derek Sha, Michael Handlogten

    Lactate is a major byproduct of Chinese hamster ovary (CHO) cell metabolism, typically accumulating during the exponential growth phase and being consumed later during the production phase. Although commonly viewed as a waste product, recent studies suggest that lactate may play a broader role in cellular regulation. To investigate this, we developed a system to modulate intracellular lactate levels by co‐expressing lactate oxidase (LOX) and catalase (CAT) in specific cellular compartments, including the cytosol, nucleus, and mitochondria. Using CHO cells secreting a bispecific antibody, this approach enabled assessment of how compartment‐specific reduction of intracellular lactate influences cell performance. Reduction of nuclear lactate levels resulted in the most pronounced improvements, including approximately 40% higher viable cell density, 35%–40% increased protein titer, and reduced oxidative stress in fed‐batch cultures. In contrast, reduction of mitochondrial lactate levels had minimal impact, indicating that the functional role of lactate is highly dependent on its subcellular localization. Further analysis demonstrated that intracellular lactate reduction was associated with decreased histone acetylation and histone lactylation, a recently described epigenetic modification linked to lactate metabolism. These epigenetic changes correlated with reduced markers of DNA damage and repair activity, suggesting improved genome stability. Overall, our findings indicate that lactate functions as more than a metabolic byproduct and may act as a regulatory metabolite influencing epigenetic state and cellular performance. Targeted modulation of intracellular lactate therefore represents a promising strategy to enhance productivity in CHO cell cultures.


  • Open Access

    Intracellular pH differentially regulates transcription of metabolic and signaling pathways in normal epithelial cells

    by Ricardo Romero-Moreno, Brandon J. Czowski, Lindsey Harris, Jessamine F. Kuehn, Katharine A. White


  • Open Access

    Intracellular pH differentially regulates transcription of metabolic and signaling pathways in normal epithelial cells

    by Ricardo Romero-Moreno, Brandon Czowski, Lindsey Harris, Jessamine F. Kuehn, Katharine A. White

    Summary: Intracellular pH (pHi) dynamics regulate normal cell function, and dysregulated pHi dynamics is an emerging hallmark of cancer (constitutively increased pHi) and neurodegeneration (constitutively decreased pHi). However, the molecular mechanisms by which pHi dynamics regulate cell biology are poorly understood. Here, we discovered that altering pHi in normal human breast epithelial cells triggers global transcriptional changes. We identified 176 genes differentially regulated by pHi, with pHi-dependent genes clustering in signaling and glycolytic pathways. Using various normal epithelial cell models, we showed pH-dependent Notch1 expression, with increased protein abundance at high pHi. This resulted in pH-dependent downstream signaling, with increased Notch1 signaling at high pHi. We also found that high pHi increased the expression of glycolytic enzymes and regulators of pyruvate fate, including lactate dehydrogenase and pyruvate dehydrogenase kinase. These transcriptional changes were sufficient to alter lactate production, with high pHi shifting these normal epithelial cells toward a glycolytic metabolism and increasing lactate production. Thus, pHi dynamics transcriptionally regulate signaling and metabolic pathways in normal epithelial cells. Our data reveal new molecular regulators of pHi-dependent biology and a role for increased pHi in driving the acquisition of cancer-associated signaling and metabolic changes in normal human epithelial cells.

  • Open Access

    Cancer and pH Dynamics: Transcriptional Regulation, Proteostasis, and the Need for New Molecular Tools

    by Brandon J. Czowski, Ricardo Romero-Moreno, Keelan J. Trull, Katharine A. White

    An emerging hallmark of cancer cells is dysregulated pH dynamics. Recent work has suggested that dysregulated intracellular pH (pHi) dynamics enable diverse cancer cellular behaviors at the population level, including cell proliferation, cell migration and metastasis, evasion of apoptosis, and metabolic adaptation. However, the molecular mechanisms driving pH-dependent cancer-associated cell behaviors are largely unknown. In this review article, we explore recent literature suggesting pHi dynamics may play a causative role in regulating or reinforcing tumorigenic transcriptional and proteostatic changes at the molecular level, and discuss outcomes on tumorigenesis and tumor heterogeneity. Most of the data we discuss are population-level analyses; lack of single-cell data is driven by a lack of tools to experimentally change pHi with spatiotemporal control. Data is also sparse on how pHi dynamics play out in complex in vivo microenvironments. To address this need, at the end of this review, we cover recent advances for live-cell pHi measurement at single-cell resolution. We also discuss the essential role for tool development in revealing mechanisms by which pHi dynamics drive tumor initiation, progression, and metastasis.


  • Open Access

    The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis

    by Ricardo Romero-Moreno, Kimberly J. Curtis, Thomas R. Coughlin, Maria Cristina Miranda-Vergara, Shourik Dutta, Aishwarya Natarajan, Beth A. Facchine, Kristen M. Jackson, Lukas Nystrom, Jun Li, et al.

    Bone is one of the most common sites for metastasis across cancers. Cancer cells that travel through the vasculature and invade new tissues can remain in a non-proliferative dormant state for years before colonizing the metastatic site. Switching from dormancy to colonization is the rate-limiting step of bone metastasis. Here we develop an ex vivo co-culture method to grow cancer cells in mouse bones to assess cancer cell proliferation using healthy or cancer-primed bones. Profiling soluble factors from conditioned media identifies the chemokine CXCL5 as a candidate to induce metastatic colonization. Additional studies using CXCL5 recombinant protein suggest that CXCL5 is sufficient to promote breast cancer cell proliferation and colonization in bone, while inhibition of its receptor CXCR2 with an antagonist blocks proliferation of metastatic cancer cells. This study suggests that CXCL5 and CXCR2 inhibitors may have efficacy in treating metastatic bone tumors dependent on the CXCL5/CXCR2 axis.


  • Open Access

    Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling

    by Eun-Kyoung Breuer, Daniela Fukushiro-Lopes, Annika Dalheim, Miranda Burnette, Jeremiah Zartman, Simon Kaja, Claire Wells, Loredana Campo, Kimberly J. Curtis, Ricardo Romero-Moreno, et al.

    Potassium ion channels are critical in the regulation of cell motility. The acquisition of cell motility is an essential parameter of cancer metastasis. However, the role of K+ channels in cancer metastasis has been poorly studied. High expression of the hG1 gene, which encodes for Kv11.1 channel associates with good prognosis in estrogen receptor-negative breast cancer (BC). We evaluated the efficacy of the Kv11.1 activator NS1643 in arresting metastasis in a triple negative breast cancer (TNBC) mouse model. NS1643 significantly reduces the metastatic spread of breast tumors in vivo by inhibiting cell motility, reprogramming epithelial–mesenchymal transition via attenuation of Wnt/β-catenin signaling and suppressing cancer cell stemness. Our findings provide important information regarding the clinical relevance of potassium ion channel expression in breast tumors and the mechanisms by which potassium channel activity can modulate tumor biology. Findings suggest that Kv11.1 activators may represent a novel therapeutic approach for the treatment of metastatic estrogen receptor-negative BC. Ion channels are critical factor for cell motility but little is known about their role in metastasis. Stimulation of the Kv11.1 channel suppress the metastatic phenotype in TNBC. This work could represent a paradigm-shifting approach to reducing mortality by targeting a pathway that is central to the development of metastases.


  • Bone: A Fertile Soil for Cancer Metastasis

    by Thomas R. Coughlin, Ricardo Romero-Moreno, Devon E. Mason, Lukas Nystrom, Joel D. Boerckel, Glen Niebur, Laurie E. Littlepage

    Bone is one of the most common and most dangerous sites for metastatic growth across cancer types, and bone metastasis remains incurable. Unfortunately, the processes by which cancers preferentially metastasize to bone are still not well understood. In this review, we summarize the morphological features, physical properties, and cell signaling events that make bone a unique site for metastasis and bone remodeling. The signaling crosstalk between the tumor cells and bone cells begins a vicious cycle – a self-sustaining feedback loop between the tumor cells and the bone microenvironment composed of osteoclasts, osteoblasts, other bone marrow cells, bone matrix, and vasculature to support both tumor growth and bone destruction. Through this crosstalk, bone provides a fertile microenvironment that can harbor dormant tumor cells, sometimes for long periods, and support their growth by releasing cytokines as the bone matrix is destroyed, similar to providing nutrients for a seed to germinate in soil. However, few models exist to study the late stages of bone colonization by metastatic tumor cells. We describe some of the current methodologies used to study bone metastasis, highlighting the limitations of these methods and alternative future strategies to be used to study bone metastasis. While in vivo animal and patient studies may provide the gold standard for studying metastasis, ex vivo models can be used as an alternative to enable more controlled experiments designed to study the late stages of bone metastasis.